Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.

Satyanarayan A, Mooney R, Bhanvadia RR, Iyengar P, Margulis V, Desai NB, Bagrodia A.

Clin Genitourin Cancer. 2019 Apr 26. pii: S1558-7673(19)30131-4. doi: 10.1016/j.clgc.2019.04.005. [Epub ahead of print] No abstract available.

PMID:
31109801
2.

Formidable Scenarios in Urothelial and Variant Cancers of the Urinary Tract.

Aragon-Ching JB, Choudhury A, Margulis V, Yu EY.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:262-275. doi: 10.1200/EDBK_237451. Epub 2019 May 17.

PMID:
31099661
3.

Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.

Woldu SL, Moore JA, Ci B, Freifeld Y, Clinton TN, Aydin AM, Singla N, Laura-Maria K, Hutchinson RC, Amatruda JF, Sagalowsky A, Lotan Y, Arriaga Y, Margulis V, Xie Y, Bagrodia A.

Eur Urol Oncol. 2018 Aug;1(3):242-251. doi: 10.1016/j.euo.2018.04.005. Epub 2018 Jun 6.

PMID:
31058267
4.

The use of cytoreductive nephrectomy in patients with renal cell carcinoma.

Ghandour RA, Singla N, Margulis V.

Expert Rev Anticancer Ther. 2019 May;19(5):405-411. doi: 10.1080/14737140.2019.1606716. Epub 2019 Apr 25.

PMID:
31020871
5.

Predicting recurrence in patients with localised renal cell carcinoma after nephrectomy.

Lotan Y, Margulis V.

Lancet Oncol. 2019 Apr;20(4):473-475. doi: 10.1016/S1470-2045(19)30024-5. Epub 2019 Mar 14. No abstract available.

PMID:
30880069
6.

Editorial Comment.

Singla N, Margulis V.

J Urol. 2019 Jun;201(6):1086. doi: 10.1097/01.JU.0000554454.85780.7a. No abstract available.

PMID:
30835609
7.

Sex differences in upper tract urothelial carcinomas.

Singla N, Ghandour RA, Margulis V.

Curr Opin Urol. 2019 May;29(3):256-260. doi: 10.1097/MOU.0000000000000596.

PMID:
30762671
8.

Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.

Aydin AM, Singla N, Panwar V, Woldu SL, Freifeld Y, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Westerman ME, Sagalowsky AI, Shariat SF, Lotan Y, Bagrodia A, Kapur P, Margulis V, Krabbe LM.

World J Urol. 2019 Feb 13. doi: 10.1007/s00345-019-02678-x. [Epub ahead of print]

PMID:
30759271
9.

Transesophageal Echocardiography Imaging of the Inferior Vena Cava and Hepatic Vein Masses.

Blinn JA, Margulis V, Joshi RV.

A A Pract. 2019 Apr 15;12(8):295-297. doi: 10.1213/XAA.0000000000000951. No abstract available.

PMID:
30633001
10.

Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma.

Petros FG, Qiao W, Singla N, Clinton TN, Robyak H, Raman JD, Margulis V, Matin SF.

Urol Oncol. 2019 Apr;37(4):292.e1-292.e9. doi: 10.1016/j.urolonc.2018.12.002. Epub 2018 Dec 22.

PMID:
30584035
11.

Editorial Comment.

Singla N, Hannan R, Margulis V.

J Urol. 2019 Jan;201(1):76. doi: 10.1097/01.ju.0000550124.15721.0f. No abstract available. Erratum in: J Urol. 2019 Apr;201(4):821.

PMID:
30577392
12.

Incidental Detection of Metastatic Penile Squamous-Cell Carcinoma With Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid (18F-Fluciclovine) PET/CT in a Patient With Recurrent Prostate Cancer.

Bhanvadia RR, Woldu SL, Margulis V, Subramaniam RM, Bagrodia A.

Clin Genitourin Cancer. 2019 Feb;17(1):e184-e186. doi: 10.1016/j.clgc.2018.10.014. Epub 2018 Oct 29. No abstract available.

PMID:
30454969
13.

Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.

Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, G Roehrborn C, Costa DN.

Urol Oncol. 2019 Jan;37(1):57-62. doi: 10.1016/j.urolonc.2018.10.009. Epub 2018 Nov 13.

PMID:
30446460
14.

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.

Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Rouprêt M, Abufaraj M, Foerster B, Gönen M, Shariat SF.

World J Urol. 2018 Nov 7. doi: 10.1007/s00345-018-2555-5. [Epub ahead of print]

15.

Need for upper urinary tract stenting in cases of ureteral orifice injury during laser enucleation of the prostate.

Enikeev D, Glybochko P, Rapoport L, Snurnitsyna O, Potoldykova N, Novoselova T, Laukhtina E, Taratkin M, Margulis V.

Int Urol Nephrol. 2018 Dec;50(12):2173-2177. doi: 10.1007/s11255-018-2007-6. Epub 2018 Oct 22.

PMID:
30349963
16.

Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study.

Woldu SL, Matulay JT, Clinton TN, Singla N, Freifeld Y, Sanli O, Krabbe LM, Hutchinson RC, Lotan Y, Hammers H, Hannan R, Brugarolas J, Bagrodia A, Margulis V.

Clin Genitourin Cancer. 2018 Dec;16(6):e1221-e1235. doi: 10.1016/j.clgc.2018.08.001. Epub 2018 Aug 25.

PMID:
30217763
17.

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.

Peyton CC, Abel EJ, Chipollini J, Boulware DC, Azizi M, Karam JA, Margulis V, Master VA, Matin SF, Raman JD, Sexton WJ, Wood CG, Spiess PE.

Eur Urol Focus. 2018 Sep 8. pii: S2405-4569(18)30242-6. doi: 10.1016/j.euf.2018.08.023. [Epub ahead of print]

PMID:
30206003
18.

Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo.

Courtney KD, Bezwada D, Mashimo T, Pichumani K, Vemireddy V, Funk AM, Wimberly J, McNeil SS, Kapur P, Lotan Y, Margulis V, Cadeddu JA, Pedrosa I, DeBerardinis RJ, Malloy CR, Bachoo RM, Maher EA.

Cell Metab. 2018 Nov 6;28(5):793-800.e2. doi: 10.1016/j.cmet.2018.07.020. Epub 2018 Aug 23.

PMID:
30146487
19.

Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.

Freifeld Y, Ananthakrishnan L, Margulis V.

Curr Urol Rep. 2018 Aug 16;19(10):82. doi: 10.1007/s11934-018-0829-5. Review.

PMID:
30116909
20.

Molecularly-driven precision medicine for advanced bladder cancer.

Krabbe LM, Margulis V, Schrader AJ, Shariat SF, Gust KM, Boegemann M.

World J Urol. 2018 Nov;36(11):1749-1757. doi: 10.1007/s00345-018-2354-z. Epub 2018 Jun 8. Review.

PMID:
29948043
21.

Therapeutic strategies for upper tract urothelial carcinoma.

Freifeld Y, Krabbe LM, Clinton TN, Woldu SL, Margulis V.

Expert Rev Anticancer Ther. 2018 Aug;18(8):765-774. doi: 10.1080/14737140.2018.1481395. Epub 2018 Jun 8. Review.

PMID:
29848133
22.

What is the role of nephrectomy following complete response to checkpoint inhibitors?

Woldu SL, Brugarolas J, Kapur P, Margulis V.

Urol Case Rep. 2018 Mar 14;18:60-63. doi: 10.1016/j.eucr.2018.02.016. eCollection 2018 May. No abstract available.

23.

Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.

Singla N, Krabbe LM, Aydin AM, Panwar V, Woldu SL, Freifeld Y, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Bagrodia A, Kapur P, Margulis V.

Urol Oncol. 2018 Jul;36(7):343.e1-343.e8. doi: 10.1016/j.urolonc.2018.04.004. Epub 2018 May 7.

PMID:
29748098
24.

Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence.

Rieken M, Kluth LA, Fajkovic H, Capitanio U, Briganti A, Krabbe LM, Margulis V, Abufaraj M, Mari A, Foerster B, Raman JD, Regelman M, Brookman-May S, Sjoberg DD, Karakiewicz PI, Shariat SF.

Clin Genitourin Cancer. 2018 Aug;16(4):e903-e908. doi: 10.1016/j.clgc.2018.03.003. Epub 2018 Mar 24.

PMID:
29653814
25.

Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps.

Lama DJ, Safiullah S, Patel RM, Lee TK, Balani JP, Zhang L, Okhunov Z, Margulis V, Savage SJ, Uchio E, Landman J.

Urology. 2018 Jul;117:89-94. doi: 10.1016/j.urology.2018.03.040. Epub 2018 Apr 6.

PMID:
29630955
26.

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus.

Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V.

Urology. 2018 May;115:119-124. doi: 10.1016/j.urology.2018.02.019. Epub 2018 Feb 27.

PMID:
29499258
27.

Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma.

Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V, Silver H, Clinton TN, Krabbe LM, Woldu SL, Singla N, Bagrodia A, Margulis V, Huang WC, Bjurlin MA, Shah O, Anderson CB.

J Urol. 2018 Jun;199(6):1440-1445. doi: 10.1016/j.juro.2018.02.002. Epub 2018 Feb 7.

PMID:
29427584
28.

Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.

Woldu SL, Ci B, Hutchinson RC, Krabbe LM, Singla N, Passoni NM, Clinton TN, Raj GV, Miller DS, Sagalowsky AI, Lotan Y, Xie Y, Margulis V, Bagrodia A.

Urol Oncol. 2018 Apr;36(4):159.e7-159.e17. doi: 10.1016/j.urolonc.2017.12.001. Epub 2017 Dec 26.

PMID:
29288008
29.

Tissue-based biomarkers in prostate cancer.

Clinton TN, Bagrodia A, Lotan Y, Margulis V, Raj GV, Woldu SL.

Expert Rev Precis Med Drug Dev. 2017;2(5):249-260. doi: 10.1080/23808993.2017.1372687. Epub 2017 Sep 5.

30.

Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States.

Singla N, Fang D, Su X, Bao Z, Cao Z, Robyak H, Xiong G, Zhang L, Woldu S, Hutchinson R, Sagalowsky A, Lotan Y, Li X, Zhou L, Raman JD, Margulis V.

Urol Oncol. 2018 Mar;36(3):88.e11-88.e18. doi: 10.1016/j.urolonc.2017.10.029. Epub 2017 Nov 23.

PMID:
29174945
31.

The Rho GTPase signalling pathway in urothelial carcinoma.

Woldu SL, Hutchinson RC, Krabbe LM, Sanli O, Margulis V.

Nat Rev Urol. 2018 Feb;15(2):83-91. doi: 10.1038/nrurol.2017.184. Epub 2017 Nov 14. Review.

PMID:
29133936
32.

Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.

Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD, Wood CG, Spiess PE.

Clin Genitourin Cancer. 2018 Apr;16(2):e443-e450. doi: 10.1016/j.clgc.2017.10.004. Epub 2017 Oct 17.

PMID:
29113770
33.

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.

Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A.

Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6.

PMID:
29079210
34.

Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.

Necchi A, Lo Vullo S, Mariani L, Moschini M, Hendricksen K, Rink M, Sosnowski R, Dobruch J, Raman JD, Wood CG, Margulis V, Roupret M, Briganti A, Montorsi F, Xylinas E, Shariat SF; European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Cancer Group and the Upper Tract Urothelial Carcinoma Collaboration group.

BJU Int. 2018 Feb;121(2):252-259. doi: 10.1111/bju.14020. Epub 2017 Oct 12.

35.

Impact of hospital case volume on testicular cancer outcomes and practice patterns.

Woldu SL, Matulay JT, Clinton TN, Singla N, Krabbe LM, Hutchinson RC, Sagalowsky A, Lotan Y, Margulis V, Bagrodia A.

Urol Oncol. 2018 Jan;36(1):14.e7-14.e15. doi: 10.1016/j.urolonc.2017.08.024. Epub 2017 Sep 19.

PMID:
28935185
36.

Robot-Assisted Versus Open Simple Prostatectomy for Benign Prostatic Hyperplasia in Large Glands: A Propensity Score-Matched Comparison of Perioperative and Short-Term Outcomes.

Sorokin I, Sundaram V, Singla N, Walker J, Margulis V, Roehrborn C, Gahan JC.

J Endourol. 2017 Nov;31(11):1164-1169. doi: 10.1089/end.2017.0489. Epub 2017 Sep 26.

PMID:
28854815
37.

Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI.

Zhang Y, Udayakumar D, Cai L, Hu Z, Kapur P, Kho EY, Pavía-Jiménez A, Fulkerson M, de Leon AD, Yuan Q, Dimitrov IE, Yokoo T, Ye J, Mitsche MA, Kim H, McDonald JG, Xi Y, Madhuranthakam AJ, Dwivedi DK, Lenkinski RE, Cadeddu JA, Margulis V, Brugarolas J, DeBerardinis RJ, Pedrosa I.

JCI Insight. 2017 Aug 3;2(15). pii: 94278. doi: 10.1172/jci.insight.94278. eCollection 2017 Aug 3.

38.

Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.

D'Andrea D, Moschini M, Foerster B, Abufaraj M, Margulis V, Karam J, Lotan Y, Raman J, Mathieu R, Rouprêt M, Karakiewicz PI, Briganti A, Haitel A, Shariat SF.

Eur Urol Focus. 2019 Jan;5(1):97-103. doi: 10.1016/j.euf.2017.06.011. Epub 2017 Jul 1.

PMID:
28753840
39.

Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy.

Hutchinson R, Singla N, Krabbe LM, Woldu S, Chen G, Rew C, Tachibana I, Lotan Y, Cadeddu JA, Margulis V.

Urol Oncol. 2017 Nov;35(11):660.e17-660.e25. doi: 10.1016/j.urolonc.2017.06.057. Epub 2017 Jul 15.

PMID:
28720410
40.

Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

Rieken M, Shariat SF, Karam JA, Foerster B, Khani F, Gust K, Abufaraj M, Wood CG, Weizer AZ, Raman JD, Guo CC, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Bachmann A, De Marzo AM, Robinson BD, Margulis V.

J Urol. 2017 Dec;198(6):1269-1277. doi: 10.1016/j.juro.2017.06.096. Epub 2017 Jul 12.

PMID:
28709887
41.

Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.

Foerster B, Moschini M, Abufaraj M, Soria F, Gust KM, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Kluth L, Mathieu R, Margulis V, Lotan Y, Aziz A, John H, Shariat SF; UTUC Collaboration.

Clin Genitourin Cancer. 2017 Dec;15(6):e1039-e1045. doi: 10.1016/j.clgc.2017.06.003. Epub 2017 Jun 19.

PMID:
28694147
42.

Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.

Xi Y, Yuan Q, Zhang Y, Madhuranthakam AJ, Fulkerson M, Margulis V, Brugarolas J, Kapur P, Cadeddu JA, Pedrosa I.

Eur Radiol. 2018 Jan;28(1):124-132. doi: 10.1007/s00330-017-4925-6. Epub 2017 Jul 5.

43.

Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma.

Krabbe LM, Heitplatz B, Preuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V.

J Urol. 2017 Dec;198(6):1253-1262. doi: 10.1016/j.juro.2017.06.086. Epub 2017 Jun 28.

PMID:
28668287
44.

Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.

Wang CJ, Christie A, Lin MH, Jung M, Weix D, Huelsmann L, Kuhn K, Meyer J, Desai N, Kim DWN, Pedrosa I, Margulis V, Cadeddu J, Sagalowsky A, Gahan J, Laine A, Xie XJ, Choy H, Brugarolas J, Timmerman R, Hannan R.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):91-100. doi: 10.1016/j.ijrobp.2017.01.032.

45.

Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.

Sorokin I, Canvasser NE, Margulis V, Lotan Y, Raj G, Sagalowsky A, Gahan JC, Cadeddu JA.

J Urol. 2017 Nov;198(5):1021-1026. doi: 10.1016/j.juro.2017.04.080. Epub 2017 Apr 23. Review.

PMID:
28442383
46.

Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.

Abel EJ, Masterson TA, Karam JA, Master VA, Margulis V, Hutchinson R, Lorentz CA, Bloom E, Bauman TM, Wood CG, Blute ML Jr.

J Urol. 2017 Oct;198(4):810-816. doi: 10.1016/j.juro.2017.04.066. Epub 2017 Apr 12.

47.

Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.

Feldkoren B, Hutchinson R, Rapoport Y, Mahajan A, Margulis V.

Exp Cell Res. 2017 Jun 15;355(2):57-66. doi: 10.1016/j.yexcr.2017.03.051. Epub 2017 Mar 29.

PMID:
28363829
48.

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer.

Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM.

Onco Targets Ther. 2017 Mar 9;10:1487-1502. doi: 10.2147/OTT.S109453. eCollection 2017. Review.

49.

Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.

Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K, Borregales LD, Sexton WJ, Patil D, Matin SF, Wood CG, Karam JA.

J Urol. 2017 Aug;198(2):281-288. doi: 10.1016/j.juro.2017.03.011. Epub 2017 Mar 6.

PMID:
28268170
50.

Renal Cell Carcinoma Metastatic to the Scalp.

Errami M, Margulis V, Huerta S.

Rare Tumors. 2016 Dec 20;8(4):6400. doi: 10.4081/rt.2016.6400. eCollection 2016 Nov 17.

Supplemental Content

Loading ...
Support Center